Penalty Amount
$49,100,000
Attorney General William Tong announced settlements with Heritage Pharmaceuticals and Apotex totaling $49.1 million to resolve allegations of price-fixing conspiracies for generic prescription drugs. The companies agreed to cooperate in ongoing multistate litigation and implement internal reforms to ensure fair competition.
The settlements require Heritage Pharmaceuticals to pay $10 million and Apotex to pay $39.1 million. Both companies must cooperate with the ongoing multistate litigation and adopt internal reforms to comply with antitrust laws and prevent future violations.
In-house legal teams should review all vendor, distributor, and customer agreements—particularly those involving generic drug supply, distribution, and co-marketing—for clauses that could enable anti-competitive behavior. Focus on pricing terms, market allocation provisions, exclusivity arrangements, and any agreements with direct competitors. Specific clauses to scrutinize include antitrust compliance certifications, audit rights, termination triggers for legal violations, and cooperation obligations in investigations. Given the settlements, contracts may need amendments to include explicit prohibitions against price-fixing and market division, mandatory antitrust training, enhanced reporting requirements, and provisions allowing for independent compliance audits to align with the internal reforms agreed to by the settling parties.
Entity
Heritage Pharmaceuticals and Apotex
Industry
HealthcareOfficial Press Release
https://portal.ct.gov/ag/press-releases/2024-press-releases/attorney-general-tong-announces-updates-in-litigation-against-generic-drug-manufacturers
AG Jepsen Leads Coalition in New Expanded Complaint in Feder
https://portal.ct.gov/AG/Press-Releases-Archived/2017-Press-Releases/AG-Jepsen-Leads-Coalition-in-New-Expanded-Complaint-in-Federal-Generic-Drug-Antitrust-Lawsuit
GDMS Complaint 51019 FINAL REDACTED PUBLIC VERSIONpdf
https://portal.ct.gov/-/media/AG/Downloads/GDMS Complaint 51019 FINAL REDACTED PUBLIC VERSIONpdf
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
$625K
Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.
$2.6M
Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.
Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.
Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.
$2.0M
Connecticut Attorney General William Tong announced a settlement with RZ Smoke, Inc. over allegations that it distributed and sold high-potency cannabis products without a state license. The stipulated judgment is $2 million, with $375,000 payable to the State and $1.6 million suspended to ensure compliance; the company is barred from specified cannabis activities in Connecticut unless licensed.
$13.7M
Connecticut joined a coalition of states and the federal government in settling allegations that Takeda paid healthcare providers speaker honoraria and provided meals to induce prescriptions of Trintellix, leading to allegedly false claims to government healthcare programs. Takeda agreed to pay $13,670,921 plus accrued interest, with portions allocated to federal and state programs.